IL17A and lobular neoplasia: Previous studies on patients with LN showed abnormal levels of IL-17A both in serum and urine; importantly, serum IL-17A levels heralded major kidney damage in patients with class IV or V glomerulonephritis [10,26,33,34,35,36], in keeping with our data.